Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited monthly Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-3.42 Insider Own2.70% Shs Outstand1.11B Perf Week-12.49%
Market Cap9.12B Forward P/E3.19 EPS next Y2.57 Insider Trans0.54% Shs Float1.05B Perf Month-0.49%
Income-3523.00M PEG- EPS next Q0.57 Inst Own62.40% Short Float4.92% Perf Quarter-43.72%
Sales18.08B P/S0.50 EPS this Y87.00% Inst Trans0.03% Short Ratio2.87 Perf Half Y-55.60%
Book/sh13.52 P/B0.61 EPS next Y8.49% ROA-5.60% Target Price14.73 Perf Year-64.79%
Cash/sh1.77 P/C4.62 EPS next 5Y-2.45% ROE-24.70% 52W Range7.96 - 25.96 Perf YTD-46.82%
Dividend- P/FCF20.31 EPS past 5Y-28.50% ROI-3.20% 52W High-68.41% Beta1.65
Dividend %- Quick Ratio0.60 Sales past 5Y-1.50% Gross Margin43.10% 52W Low3.02% ATR0.46
Employees42535 Current Ratio1.00 Sales Q/Q-15.20% Oper. Margin-16.70% RSI (14)35.03 Volatility4.81% 4.97%
OptionableYes Debt/Eq1.94 EPS Q/Q-114.70% Profit Margin-19.70% Rel Volume0.92 Prev Close8.56
ShortableYes LT Debt/Eq1.75 EarningsAug 07 BMO Payout- Avg Volume17.97M Price8.20
Recom2.80 SMA20-7.81% SMA50-19.43% SMA200-50.06% Volume16,525,645 Change-4.21%
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19Resumed Credit Suisse Neutral
Jul-05-19Upgrade Argus Hold → Buy
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
Mar-20-19Initiated SunTrust Hold
Mar-07-19Resumed UBS Buy $22
Mar-06-19Downgrade Morgan Stanley Overweight → Equal-Weight $17
Feb-20-19Downgrade Mizuho Buy → Neutral $25 → $18
Feb-14-19Upgrade Raymond James Mkt Perform → Outperform $22
Jan-23-19Upgrade UBS Neutral → Buy
Jan-23-19Upgrade Piper Jaffray Underweight → Neutral
Jan-03-19Upgrade BofA/Merrill Underperform → Buy
Nov-05-18Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-01-18Upgrade Leerink Partners Underperform → Mkt Perform
Sep-21-18Resumed Oppenheimer Perform
Sep-17-18Upgrade BTIG Research Sell → Neutral
Sep-07-18Downgrade Credit Suisse Outperform → Neutral
Jul-16-19 11:45PM  Opioid makers dumped 76 billion pills onto U.S. market over 7 critical years, data shows MarketWatch
10:00PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CLDR, TEVA and FRED ACCESSWIRE
09:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, Teva Pharmaceutical Industries, and Helius Medical Technologies and Encourages Investors to Contact the Firm GlobeNewswire
03:16PM  Teva Shares Fall Further as Morgan Stanley Downgrades Rating Zacks
01:42PM  Option Trader Makes Bullish Bet On Lannett Rebound Benzinga
12:15PM  CLASS ACTION UPDATE for EROS, TEVA and FRED: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:23AM  J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View Zacks
10:19AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
09:09AM  CLASS ACTION UPDATE for BUD, TEVA, EQT and INS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
Jul-15-19 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BUD, EROS, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire -7.46%
04:36PM  Teva Pharmaceuticals News: Why TEVA Stock Is Sliding Today InvestorPlace
04:33PM  Why Callon Petroleum, Teva Pharmaceutical Industries, and PG&E Slumped Today Motley Fool
01:28PM  UPDATE 4-Opioid 'kingpin' J&J fueled epidemic, Oklahoma argues at trial's end Reuters
12:00PM  Teva Relief Rally Loses Steam After Analyst Downgrade Investopedia
11:30AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASNA, BUD and TEVA ACCESSWIRE
11:07AM  CORRECTED-UPDATE 2-Oklahoma at trial's end says opioid 'kingpin' J&J fueled epidemic Reuters
10:35AM  Morgan Stanley Downgrades Teva, Endo On Drug Pricing And Litigation Concerns Benzinga
10:23AM  Class Action Reminder - ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
10:19AM  Teva and Endo Stock Are Falling Because Opioid Suits Arent Going Away Barrons.com
08:30AM  Teva Announces FDA Approval of AirDuo® Digihaler (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder Business Wire
06:00AM  Oklahoma, J&J to wrap up first trial over opioid crisis Reuters
05:36AM  [video]Teva Shares Slump on Opioid Litigation Risk Downgrade From Morgan Stanley TheStreet.com
Jul-14-19 11:01AM  SHAREHOLDER ALERT: PSMT TEVA FDX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Jul-12-19 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BUD, EROS, PSMT, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
03:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PYX, TEVA and FDX ACCESSWIRE
03:00PM  ASNA,  BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement GlobeNewswire
12:09PM  Teva buys three buildings in West Chester for its R&D campus American City Business Journals
11:20AM  CLASS ACTION UPDATE for MBNKF, MOMO and TEVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:49AM  ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC Class Action Update ACCESSWIRE
12:00AM  3 Top Value Stocks to Buy in July Motley Fool
Jul-11-19 04:21PM  Amneal (AMRX) Down on Guidance Update & Restructuring Plan Zacks
09:23AM  SHAREHOLDER ALERT: TUSK ASNA ZUO TEVA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
08:07AM  Teva Completes Facilities Purchase in Pennsylvania for North America Research & Development Campus Business Wire
08:00AM  Pfizer Stock Is The Biggest Pharma But Should You Buy It? Investor's Business Daily
Jul-10-19 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BUD, EROS, PSMT, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
02:07PM  Theres Nothing to Give Them: The Hunt for Lifesaving Epipens Bloomberg
12:43PM  EpiPen Shortage: Mylan (MYL) Stock Falls on Continued Scarce Supply InvestorPlace
11:25AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MBNKF, ASNA and TEVA ACCESSWIRE
11:24AM  Court Ruling Topples Trump Order, No Price Display in TV Ads Zacks
10:48AM  ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
10:22AM  Jazz (JAZZ) Acquires Early-Stage Precision Oncology Asset Zacks
09:17AM  Teva to Present New Data on AJOVY® (fremanezumab-vfrm) Injection at the American Headache Societys 61st Annual Scientific Meeting Business Wire
Jul-09-19 10:00AM  CLASS ACTION UPDATE for MOMO, RMED, TEVA and DBD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
03:19AM  Stocks - Futures Slump on Earnings Fears; Powell Speech Eyed Investing.com
Jul-08-19 10:59PM  BARJO LAW INVESTOR ALERT: Barbuto & Johansson, P.A. Advises TUSK, TEVA, COTY and NOAH Shareholders of Class Action Lawsuits and Investigations GlobeNewswire
10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BUD, EQT, EROS, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
12:25PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PSMT, LTHM and TEVA ACCESSWIRE
10:48AM  ASNA, BUD & TEVA - Bronstein, Gewirtz & Grossman, LLC Class Action Announcement ACCESSWIRE
09:18AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MBNKF, XENT, BUD and TEVA GlobeNewswire
Jul-06-19 03:04PM  Bulls And Bears Of The Week: Apple, Nike, Tesla, Uber And More Benzinga
Jul-05-19 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS REV, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
03:45PM  SHAREHOLDER ALERT: XENT ZUO TEVA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:43PM  Teva Stock Upgraded: What You Need to Know Motley Fool
03:00PM  SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Shareholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 GlobeNewswire
12:45PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MBNKF, TUSK and TEVA ACCESSWIRE
11:10AM  Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. TEVA GlobeNewswire
10:49AM  SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Stockholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 ACCESSWIRE
09:55AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of PSMT, JMIA and TEVA ACCESSWIRE
Jul-04-19 07:36AM  2 Stocks Wall Street Hates That I've Been Buying Motley Fool
Jul-03-19 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BUD, EQT, EROS, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
05:00PM  Teva to Host Conference Call to Discuss Second Quarter 2019 Financial Results at 8 a.m. ET on August 7, 2019 Business Wire
09:25AM  CLASS ACTION UPDATE for HL, PVTL, CLDR and TEVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
08:30AM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, and Teva Pharmaceutical Industries and Encourages Investors to Contact the Firm GlobeNewswire
Jul-02-19 05:50PM  Teva Pharmaceutical Industries Ltd. (TEVA) Outpaces Stock Market Gains: What You Should Know Zacks
02:20PM  CLASS ACTION UPDATE for TEVA, FDX and EQT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:50PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
12:20PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BUD, EROS, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
11:40AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of TEVA, FDX and EQT ACCESSWIRE
10:48AM  SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Investors of Class Action and Lead Plaintiff Deadline: August 20, 2019 ACCESSWIRE
10:29AM  Teva's Migraine Prevention Drug Meets Exploratory Endpoints Benzinga
10:27AM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
09:31AM  Regeneron/Sanofi's Libtayo Gets EU Approval for Skin Cancer Zacks
09:21AM  Stocks - Anheuser Busch, Revolve Group Rise Premarket; Nike Falls Investing.com
09:01AM  AstraZeneca Gets CHMP Nod for Forxiga/Fasenra Expanded Label Zacks
07:29AM  The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug Benzinga
02:30AM  Teva Presents Positive Results Showing Improvement in Disability and Quality of Life from the Phase IIIb FOCUS study of Fremanezumab in Adults with Migraine Business Wire
Jul-01-19 08:55AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of JMIA, HL, EROS and TEVA GlobeNewswire
08:30AM  Teva Announces Launch of 1% Sodium Hyaluronate in the United States Business Wire
03:00AM  Barbuto & Johansson, P.A. Informs Investors of the Pending Class Action Lawsuit Against Teva Pharmaceutical and Encourages Investors to Contact the Firm GlobeNewswire
Jun-30-19 06:00PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
10:15AM  The Gross Law Firm Announces Class Actions on Behalf of Shareholders of EROS, TEVA and FDX ACCESSWIRE
Jun-29-19 08:14AM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jun-28-19 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BUD, EQT, EROS, TEVA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
12:39PM  7 F-Rated Stocks to Sell for Summer InvestorPlace
08:10AM  SHAREHOLDER ALERT: PSMT MBNKF TEVA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Jun-27-19 09:30PM  Bragar Eagel & Squire Reminds Investors That Class Action Lawsuits have been filed against Pivotal Software, Eros International, and Teva Pharmaceutical Industries and Encourages Investors to Contact the Firm GlobeNewswire
07:55PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
03:10PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of MBNKF, EROS and TEVA ACCESSWIRE
03:00PM  SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Shareholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 GlobeNewswire
10:47AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:24AM  SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Lead Plaintiff Deadline: August 20, 2019 ACCESSWIRE
10:10AM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. TEVA GlobeNewswire
09:13AM  CLASS ACTION UPDATE for LYFT, JMIA, EROS and TEVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:10AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PYX, EROS and TEVA ACCESSWIRE
Jun-26-19 09:50PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TUSK, PYX and TEVA ACCESSWIRE
08:37PM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
07:00PM  TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA PR Newswire
06:30PM  CLASS ACTION UPDATE for KSHB, EROS and TEVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
05:50PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know Zacks
04:45PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides specialty medicines for use in central nervous system and respiratory indications. Its products in the central nervous system area comprise Copaxone for the treatment of relapsing forms of MS; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. The company has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARER SOL JDirectorJun 04Buy9.60104,5001,003,409220,442Jun 05 07:02 AM
BARER SOL JDirectorJun 03Buy8.98111,000997,013115,942Jun 03 11:21 AM
de Notaristefani CarloExecutive VP Global OperationsMay 20Sale11.4216,070183,51933,589May 21 06:38 AM
de Notaristefani CarloExecutive VP Global OperationsMay 16Sale11.766297,39718,784May 20 07:18 AM
O'Grady Brendan P.EVP, North America CommercialMar 18Sale16.631,17919,6011,388Mar 19 08:29 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 18Sale16.643205,3269,002Mar 19 08:17 AM
Daniell RichardExec. VP, European CommercialMar 18Sale16.641,29721,5880Mar 19 08:14 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 18Sale16.432,35838,7422,974Mar 19 08:11 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 18Sale16.632303,82412,760Mar 19 08:08 AM
Griffin Deborah AChief Accounting OfficerMar 18Sale16.6394315,6770Mar 19 08:06 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 18Sale16.633565,91916,750Mar 19 08:04 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 18Sale16.6363210,5079,149Mar 19 08:02 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 12Sale15.822,44438,6642,974Mar 14 07:44 AM
O'Grady Brendan P.EVP, North America CommercialMar 12Sale15.6773811,5681,388Mar 14 07:41 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 12Sale15.693255,0998,450Mar 14 07:36 AM
Griffin Deborah AChief Accounting OfficerMar 12Sale15.6795314,9380Mar 14 07:33 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 12Sale15.6764710,1428,602Mar 14 07:31 AM
Daniell RichardExec. VP, European CommercialMar 12Sale15.6971511,2180Mar 14 07:28 AM
O'Grady Brendan P.EVP, North America CommercialMar 04Sale16.881,16619,6861,388Mar 05 07:36 AM
McClellan Michael JamesEVP, Chief Financial OfficerMar 04Sale16.883636,12912,330Mar 05 07:28 AM
Griffin Deborah AChief Accounting OfficerMar 04Sale16.884,10769,3400Mar 05 07:23 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 04Sale16.884096,90516,094Mar 05 07:16 AM
Dethlefs SvenEVP Global Marketing&PortfolioMar 04Sale16.8860610,2318,058Mar 05 07:10 AM
Daniell RichardExec. VP, European CommercialMar 04Sale16.882,09835,4230Mar 05 07:05 AM
Nazzi GianfrancoEVP, Growth Markets CommercialMar 04Sale16.885128,6457,892Mar 05 08:20 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 14Sale17.743,92669,6472,974Feb 19 07:26 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 14Sale17.673,19256,39918,209Feb 19 07:05 AM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 14Sale17.671,84132,52915,338Feb 19 07:11 AM
de Notaristefani CarloExecutive VP Global OperationsFeb 13Sale17.885,04190,10812,121Feb 14 07:43 AM
Fridriksdottir HafrunExecutive VP, Global R&DJan 02Sale15.701,64325,79911,826Jan 03 07:24 AM
Fridriksdottir HafrunExecutive VP, Global R&DNov 30Sale21.7693320,3048,829Dec 04 08:09 AM
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale22.733467,86511,644Nov 07 06:38 AM
Daniell RichardExec. VP, European CommercialSep 18Sale23.692,48858,9430Sep 20 04:04 PM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale23.711,24129,4201,388Sep 20 04:10 PM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale23.691,37932,6707,005Sep 20 04:09 PM
Griffin Deborah AChief Accounting OfficerSep 18Sale23.712,37656,3280Sep 20 04:08 PM
Dethlefs SvenEVP Global Marketing&PortfolioSep 18Sale23.7162514,8177,265Sep 20 04:06 PM
Daniell RichardExec. VP, European CommercialSep 10Sale21.2569614,7900Sep 11 04:17 PM
Codner Iris BeckEVP Global Brand&CommunicationAug 09Sale22.704,16594,5418,290Aug 13 08:34 AM
Dethlefs SvenEVP Global Marketing&PortfolioAug 03Buy21.922,00043,8406,445Aug 07 09:45 AM